- IBDEI0FN ; ; 03-MAY-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
- Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.4)
- ;;=^IBE(358.4,
- ;;^UTILITY(U,$J,358.4,0)
- ;;=IMP/EXP SELECTION GROUP^358.4I^1536^1504
- ;;^UTILITY(U,$J,358.4,1,0)
- ;;=NEW PATIENT^2^1
- ;;^UTILITY(U,$J,358.4,2,0)
- ;;=ESTABLISHED PATIENT^1^1
- ;;^UTILITY(U,$J,358.4,3,0)
- ;;=CONSULTATIONS^3^1
- ;;^UTILITY(U,$J,358.4,4,0)
- ;;=ALLERGY DIAGNOSES^1^2
- ;;^UTILITY(U,$J,358.4,5,0)
- ;;=IMMUNODEFICIENCY^2^2
- ;;^UTILITY(U,$J,358.4,6,0)
- ;;=OTHER^3^2
- ;;^UTILITY(U,$J,358.4,7,0)
- ;;=IMMUNIZATION^4^3
- ;;^UTILITY(U,$J,358.4,8,0)
- ;;=SKIN TEST^9^3
- ;;^UTILITY(U,$J,358.4,9,0)
- ;;=ALLERGENIC EXTRACT^1^3
- ;;^UTILITY(U,$J,358.4,10,0)
- ;;=PATCH TESTS^8^3
- ;;^UTILITY(U,$J,358.4,11,0)
- ;;=ALLERGY INJECTION/EXTRACT^2^3
- ;;^UTILITY(U,$J,358.4,12,0)
- ;;=LABORATORY^6^3
- ;;^UTILITY(U,$J,358.4,13,0)
- ;;=INFUSIONS^5^3
- ;;^UTILITY(U,$J,358.4,14,0)
- ;;=OTHER^7^3
- ;;^UTILITY(U,$J,358.4,15,0)
- ;;=EDUCATION/TRAINING^1^4
- ;;^UTILITY(U,$J,358.4,16,0)
- ;;=FAMILY TRAINING-GROUP^2^4
- ;;^UTILITY(U,$J,358.4,17,0)
- ;;=PROCEDURE CODES-GROUP^3^4
- ;;^UTILITY(U,$J,358.4,18,0)
- ;;=RECREATION THERAPY DX^1^5
- ;;^UTILITY(U,$J,358.4,19,0)
- ;;=SDOH^2^5
- ;;^UTILITY(U,$J,358.4,20,0)
- ;;=1-1 THERAPEUTIC PROCEDURES^1^6
- ;;^UTILITY(U,$J,358.4,21,0)
- ;;=EDUCATION/TRAINING^3^6
- ;;^UTILITY(U,$J,358.4,22,0)
- ;;=TEAM CONFERENCE^6^6
- ;;^UTILITY(U,$J,358.4,23,0)
- ;;=ASSESSMENT^2^6
- ;;^UTILITY(U,$J,358.4,24,0)
- ;;=FAMILY TRAINING^4^6
- ;;^UTILITY(U,$J,358.4,25,0)
- ;;=SPECIALTY PROCEDURES-INDIVIDUAL^5^6
- ;;^UTILITY(U,$J,358.4,26,0)
- ;;=RECREATION THERAPY DX^1^7
- ;;^UTILITY(U,$J,358.4,27,0)
- ;;=SDOH^2^7
- ;;^UTILITY(U,$J,358.4,28,0)
- ;;=SPECIAL SERVICES^10^8
- ;;^UTILITY(U,$J,358.4,29,0)
- ;;=CHEMO NURSE PROCEDURES^2^8
- ;;^UTILITY(U,$J,358.4,30,0)
- ;;=INFUSION DRUGS^7^8
- ;;^UTILITY(U,$J,358.4,31,0)
- ;;=BLOOD PRODUCTS^1^8
- ;;^UTILITY(U,$J,358.4,32,0)
- ;;=DIAGNOSTIC PROCEDURES^3^8
- ;;^UTILITY(U,$J,358.4,33,0)
- ;;=OTHER DRUGS^8^8
- ;;^UTILITY(U,$J,358.4,34,0)
- ;;=IMMUNIZATION ADMINISTRATION^5^8
- ;;^UTILITY(U,$J,358.4,35,0)
- ;;=IMMUNIZATIONS^6^8
- ;;^UTILITY(U,$J,358.4,36,0)
- ;;=PROLONGED SVC-MD/NP/PA^9^8
- ;;^UTILITY(U,$J,358.4,37,0)
- ;;=EDUCATION/TRAINING^4^8
- ;;^UTILITY(U,$J,358.4,38,0)
- ;;=NEW PATIENT^2^9
- ;;^UTILITY(U,$J,358.4,39,0)
- ;;=ESTABLISHED PATIENT^1^9
- ;;^UTILITY(U,$J,358.4,40,0)
- ;;=CONSULTATIONS^3^9
- ;;^UTILITY(U,$J,358.4,41,0)
- ;;=COMPLEX CHRONIC CARE^4^9
- ;;^UTILITY(U,$J,358.4,42,0)
- ;;=ANEMIA^1^10
- ;;^UTILITY(U,$J,358.4,43,0)
- ;;=ARTIFICIAL OPENING STATUS^2^10
- ;;^UTILITY(U,$J,358.4,44,0)
- ;;=BREASTS and GYN NEOPLASMS^3^10
- ;;^UTILITY(U,$J,358.4,45,0)
- ;;=COAGULATION DISORDERS^4^10
- ;;^UTILITY(U,$J,358.4,46,0)
- ;;=COUNSELING AND SCREENING^5^10
- ;;^UTILITY(U,$J,358.4,47,0)
- ;;=GENITOURINARY NEOPLASMS^6^10
- ;;^UTILITY(U,$J,358.4,48,0)
- ;;=GI CANCER^7^10
- ;;^UTILITY(U,$J,358.4,49,0)
- ;;=HEAD NECK AND LUNGS NEOPLASMS^8^10
- ;;^UTILITY(U,$J,358.4,50,0)
- ;;=HEMOGLOBINOPATHIES^9^10
- ;;^UTILITY(U,$J,358.4,51,0)
- ;;=LYMPHOID NEOPLASMS^10^10
- ;;^UTILITY(U,$J,358.4,52,0)
- ;;=METASTATIC SITES^13^10
- ;;^UTILITY(U,$J,358.4,53,0)
- ;;=MALIGNANT NEOPLASMS OF OTHER SITES^11^10
- ;;^UTILITY(U,$J,358.4,54,0)
- ;;=MYELOID NEOPLASMS AND DISORDERS^14^10
- ;;^UTILITY(U,$J,358.4,55,0)
- ;;=NEOPLASM OF UNCERTAIN BEHAVIOR^15^10
- ;;^UTILITY(U,$J,358.4,56,0)
- ;;=NEOPLASM OF UNSPECIFIED NATURE^16^10
- ;;^UTILITY(U,$J,358.4,57,0)
- ;;=PERSONAL HISTORY^19^10
- ;;^UTILITY(U,$J,358.4,58,0)
- ;;=MALNUTRITION^12^10
- ;;^UTILITY(U,$J,358.4,59,0)
- ;;=OTHER^18^10
- ;;^UTILITY(U,$J,358.4,60,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^20^10
- ;;^UTILITY(U,$J,358.4,61,0)
- ;;=ESTABLISHED PATIENT^1^11
- ;;^UTILITY(U,$J,358.4,62,0)
- ;;=CARE PLAN OVERSIGHT^1^12
- ;;^UTILITY(U,$J,358.4,63,0)
- ;;=OTHER SERVICES^4^12
- ;;^UTILITY(U,$J,358.4,64,0)
- ;;=CASE MANAGEMENT^2^12
- ;;^UTILITY(U,$J,358.4,65,0)
- ;;=EDUCATION^3^12
- ;;^UTILITY(U,$J,358.4,66,0)
- ;;=CARDIOVASCULAR DISORDERS^1^13
- ;;^UTILITY(U,$J,358.4,67,0)
- ;;=CONDITIONS AFFECTING HEALTH CARE STATUS^2^13
- ;;^UTILITY(U,$J,358.4,68,0)
- ;;=DIABETES^4^13
- ;;^UTILITY(U,$J,358.4,69,0)
- ;;=EYE & EAR DISORDERS^4^13
- ;;^UTILITY(U,$J,358.4,70,0)
- ;;=MENTAL HEALTH^5^13
- ;;^UTILITY(U,$J,358.4,71,0)
- ;;=NEOPLASMS^6^13
- ;;^UTILITY(U,$J,358.4,72,0)
- ;;=NEUROLOGICAL CONDITIONS^7^13
- ;;^UTILITY(U,$J,358.4,73,0)
- ;;=OTHER CONDITIONS^8^13
- ;;^UTILITY(U,$J,358.4,74,0)
- ;;=RESPIRATORY DISORDERS^9^13
- ;;^UTILITY(U,$J,358.4,75,0)
- ;;=DEMENTIA^3^13
- ;;^UTILITY(U,$J,358.4,76,0)
- ;;=ACOUSTIC NERVE INJURIES^1^14
- ;;^UTILITY(U,$J,358.4,77,0)
- ;;=AUDITORY DISORDERS^2^14
- ;;^UTILITY(U,$J,358.4,78,0)
- ;;=BALANCE DISORDERS^3^14
- ;;^UTILITY(U,$J,358.4,79,0)
- ;;=BAROTRAUMA^4^14
- ;;^UTILITY(U,$J,358.4,80,0)
- ;;=EAR DISEASE^5^14
- ;;^UTILITY(U,$J,358.4,81,0)
- ;;=FOREIGN BODIES^7^14
- ;;^UTILITY(U,$J,358.4,82,0)
- ;;=HEARING LOSS^8^14
- ;;^UTILITY(U,$J,358.4,83,0)
- ;;=NOISE INJURIES^9^14
- ;;^UTILITY(U,$J,358.4,84,0)
- ;;=NYSTAGMUS^10^14
- ;;^UTILITY(U,$J,358.4,85,0)
- ;;=OTOTOXICITY^11^14
- ;;^UTILITY(U,$J,358.4,86,0)
- ;;=PURPOSE OF ENCOUNTER/HEALTH STATUS^12^14
- ;;^UTILITY(U,$J,358.4,87,0)
- ;;=EXTERNAL EAR DISEASES^6^14
- ;;^UTILITY(U,$J,358.4,88,0)
- ;;=NEW PATIENT^2^15
- ;;^UTILITY(U,$J,358.4,89,0)
- ;;=ESTABLISHED PATIENT^1^15
- ;;^UTILITY(U,$J,358.4,90,0)
- ;;=CONSULTATIONS^3^15
- ;;^UTILITY(U,$J,358.4,91,0)
- ;;=AUDIOLOGIC FUNCTION TESTS^1^16
- ;;^UTILITY(U,$J,358.4,92,0)
- ;;=SCREENING^13^16
- ;;^UTILITY(U,$J,358.4,93,0)
- ;;=COCHLEAR IMPLANT^3^16
- ;;^UTILITY(U,$J,358.4,94,0)
- ;;=OTHER TREATMENT^10^16
- ;;^UTILITY(U,$J,358.4,95,0)
- ;;=DISPENSING^5^16
- ;;^UTILITY(U,$J,358.4,96,0)
- ;;=REMOVAL FOREIGN BODY/CERUMEN^12^16
- ;;^UTILITY(U,$J,358.4,97,0)
- ;;=VESTIBULAR FUNCT W/ RECORDING^15^16
- ;;^UTILITY(U,$J,358.4,98,0)
- ;;=VESTIBULAR FUNCT W/O RECORDING^16^16
- ;;^UTILITY(U,$J,358.4,99,0)
- ;;=EVALUATIVE & THERAPEUTIC SVCS^6^16
- ;;^UTILITY(U,$J,358.4,100,0)
- ;;=TEAM CONFERENCE^14^16
- ;;^UTILITY(U,$J,358.4,101,0)
- ;;=PROLONGED CLINICAL STAFF SERVICES^11^16
- ;;^UTILITY(U,$J,358.4,102,0)
- ;;=OTHER SERVICES^9^16
- ;;^UTILITY(U,$J,358.4,103,0)
- ;;=DEVICES & EQUIPMENT^4^16
- ;;^UTILITY(U,$J,358.4,104,0)
- ;;=EXCISION^7^16
- ;;^UTILITY(U,$J,358.4,105,0)
- ;;=INCISION^8^16
- ;;^UTILITY(U,$J,358.4,106,0)
- ;;=AUTOMATED AUDIOMETRY^2^16
- ;;^UTILITY(U,$J,358.4,107,0)
- ;;=NEW PATIENT^2^17
- ;;^UTILITY(U,$J,358.4,108,0)
- ;;=ESTABLISHED PATIENT^1^17
- ;;^UTILITY(U,$J,358.4,109,0)
- ;;=CONSULTATIONS^3^17
- ;;^UTILITY(U,$J,358.4,110,0)
- ;;=ARRHYTHMIA^3^18
- ;;^UTILITY(U,$J,358.4,111,0)
- ;;=CHEST PAIN^4^18
- ;;^UTILITY(U,$J,358.4,112,0)
- ;;=CHF/MYOPATHY/TRANSPLANT^5^18
- ;;^UTILITY(U,$J,358.4,113,0)
- ;;=CORONARY ATHEROSCLEROSIS^6^18
- ;;^UTILITY(U,$J,358.4,114,0)
- ;;=GENERAL SYMPTOMS^9^18
- ;;^UTILITY(U,$J,358.4,115,0)
- ;;=HISTORY^12^18
- ;;^UTILITY(U,$J,358.4,116,0)
- ;;=HYPERTENSION/HYPOTENSION^13^18
- ;;^UTILITY(U,$J,358.4,117,0)
- ;;=INFECTION/INFLM DISEASE^14^18
- ;;^UTILITY(U,$J,358.4,118,0)
- ;;=LIPID DISORDER^15^18
- ;;^UTILITY(U,$J,358.4,119,0)
- ;;=MYOCARDIAL INFARCTION^17^18
- ;;^UTILITY(U,$J,358.4,120,0)
- ;;=NONRHEUMATIC HEART VALVE DISORDERS^18^18
- ;;^UTILITY(U,$J,358.4,121,0)
- ;;=HEART DISEASE^10^18
- ;;^UTILITY(U,$J,358.4,122,0)
- ;;=HEART VALVE DISEASE^11^18
- ;;^UTILITY(U,$J,358.4,123,0)
- ;;=PERIPHERAL VASC DISEASE^20^18
- ;;^UTILITY(U,$J,358.4,124,0)
- ;;=RHEUMATIC HEART DISEASE^23^18
- ;;^UTILITY(U,$J,358.4,125,0)
- ;;=DEVICE/IMPLANT/GRAFT^7^18
- ;;^UTILITY(U,$J,358.4,126,0)
- ;;=SYNCOPE^26^18
- ;;^UTILITY(U,$J,358.4,127,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^24^18
- ;;^UTILITY(U,$J,358.4,128,0)
- ;;=ECTOPY^8^18
- ;;^UTILITY(U,$J,358.4,129,0)
- ;;=MISCELLANEOUS^16^18
- ;;^UTILITY(U,$J,358.4,130,0)
- ;;=VENTRICULAR ARRHYTHMIAS^27^18
- ;;^UTILITY(U,$J,358.4,131,0)
- ;;=SUPRAVENTRICULAR ARRHYTHMIAS^25^18
- ;;^UTILITY(U,$J,358.4,132,0)
- ;;=OTHER CARDIAC CONDITIONS^22^18
- ;;^UTILITY(U,$J,358.4,133,0)
- ;;=PULMONARY DISEASE^21^18
- ;;^UTILITY(U,$J,358.4,134,0)
- ;;=PACEMAKER/AIC/DEFIBRILLATOR^19^18
- ;;^UTILITY(U,$J,358.4,135,0)
- ;;=ACSC CHF^1^18
- ;;^UTILITY(U,$J,358.4,136,0)
- ;;=ACSC HYPERTENSION^2^18
- ;;^UTILITY(U,$J,358.4,137,0)
- ;;=PACEMAKER^15^19
- ;;^UTILITY(U,$J,358.4,138,0)
- ;;=CORONARY ANGIOPLASTY & STENTS^3^19
- ;;^UTILITY(U,$J,358.4,139,0)
- ;;=ELECTROPHYSIOLOGICAL PROCs^7^19
- ;;^UTILITY(U,$J,358.4,140,0)
- ;;=PERIPHERAL ANGIOPLASTIES & STENTS^16^19
- ;;^UTILITY(U,$J,358.4,141,0)
- ;;=VASCULAR INJECTION PROCs^21^19
- ;;^UTILITY(U,$J,358.4,142,0)
- ;;=OTHER PROCEDURES^14^19
- ;;^UTILITY(U,$J,358.4,143,0)
- ;;=HEART CATHETERIZATIONS^8^19
- ;;^UTILITY(U,$J,358.4,144,0)
- ;;=CATHETERIZATIONS FOR INT RADIOLOGY^2^19
- ;;^UTILITY(U,$J,358.4,145,0)
- ;;=OTHER HEART CODES^13^19
- ;;^UTILITY(U,$J,358.4,146,0)
- ;;=PROSTHETIC ANEURYSM REPAIR^19^19
- ;;^UTILITY(U,$J,358.4,147,0)
- ;;=DEVICE PROGRAMMING^4^19
- ;;^UTILITY(U,$J,358.4,148,0)
- ;;=ECHO^5^19
- ;;^UTILITY(U,$J,358.4,149,0)
- ;;=EKG^6^19
- ;;^UTILITY(U,$J,358.4,150,0)
- ;;=MEDICATION ADMINISTRATION^9^19
- ;;^UTILITY(U,$J,358.4,151,0)
- ;;=MEDICATIONS^10^19
- ;;^UTILITY(U,$J,358.4,152,0)
- ;;=OTHER CARDIAC^12^19
- ;;^UTILITY(U,$J,358.4,153,0)
- ;;=STRESS TESTS^20^19
- ;;^UTILITY(U,$J,358.4,154,0)
- ;;=PREVENTIVE COUNSELING^17^19
- ;;^UTILITY(U,$J,358.4,155,0)
- ;;=MODERATE SEDATION (MS)^11^19
- ;;^UTILITY(U,$J,358.4,156,0)
- ;;=VENTRICULAR ASSIST DEVICE INSERTION^22^19
- ;;^UTILITY(U,$J,358.4,157,0)
- ;;=CARDIOVERSION^1^19
- ;;^UTILITY(U,$J,358.4,158,0)
- ;;=PROLONGED SERVICES^18^19
- ;;^UTILITY(U,$J,358.4,159,0)
- ;;=COUNSELING/EDUCATION^5^20
- ;;^UTILITY(U,$J,358.4,160,0)
- ;;=PSYCHIATRIC THERAPY^10^20
- ;;^UTILITY(U,$J,358.4,161,0)
- ;;=BIOFEEDBACK THERAPY^2^20
- ;;^UTILITY(U,$J,358.4,162,0)
- ;;=BIOPSYCHOSOCIAL ASSESS/INTERVENTION^3^20
- ;;^UTILITY(U,$J,358.4,163,0)
- ;;=PHYSICAL THERAPY^9^20
- ;;^UTILITY(U,$J,358.4,164,0)
- ;;=OTHER THERAPEUTIC TECHNIQUES^8^20
- ;;^UTILITY(U,$J,358.4,165,0)
- ;;=ACUPUNTURE^1^20
- ;;^UTILITY(U,$J,358.4,166,0)
- ;;=OSTEOPATHIC MANIPULATION^7^20
- ;;^UTILITY(U,$J,358.4,167,0)
- ;;=CHIROPRACTIC MANIPULATION^4^20
- ;;^UTILITY(U,$J,358.4,168,0)
- ;;=SELF-MANAGEMENT TRAINING^11^20
- ;;^UTILITY(U,$J,358.4,169,0)
- ;;=NUTRITION APPROACHES^6^20
- ;;^UTILITY(U,$J,358.4,170,0)
- ;;=VA WHOLE HEALTH PARTNER SVCS^12^20
- ;;^UTILITY(U,$J,358.4,171,0)
- ;;=COUNSELING^2^21
- ;;^UTILITY(U,$J,358.4,172,0)
- ;;=HISTORY OF ILLNESS^7^21
- ;;^UTILITY(U,$J,358.4,173,0)
- ;;=OTHER^19^21
- ;;^UTILITY(U,$J,358.4,174,0)
- ;;=SCREENING^14^21
- ;;^UTILITY(U,$J,358.4,175,0)
- ;;=CARDIOVASCULAR DISORDER^1^21
- ;;^UTILITY(U,$J,358.4,176,0)
- ;;=DIABETIC MANAGEMENT^3^21
- ;;^UTILITY(U,$J,358.4,177,0)
- ;;=ENDOCRINE DISORDER^4^21
- ;;^UTILITY(U,$J,358.4,178,0)
- ;;=HEARING DISORDER^6^21
- ;;^UTILITY(U,$J,358.4,179,0)
- ;;=GASTROINTESTINAL DISORDER^5^21
- ;;^UTILITY(U,$J,358.4,180,0)
- ;;=INJURIES^8^21
- ;;^UTILITY(U,$J,358.4,181,0)
- ;;=NEOPLASM^11^21
- ;;^UTILITY(U,$J,358.4,182,0)
- ;;=RESPIRATORY DISORDER^13^21
- ;;^UTILITY(U,$J,358.4,183,0)
- ;;=SIGNS AND SYMPTOMS^15^21
- ;;^UTILITY(U,$J,358.4,184,0)
- ;;=SUBSTANCE DISORDERS^16^21
- ;;^UTILITY(U,$J,358.4,185,0)
- ;;=WEIGHT MANAGEMENT^18^21
- ;;^UTILITY(U,$J,358.4,186,0)
- ;;=MOOD DISORDER^9^21
- ;;^UTILITY(U,$J,358.4,187,0)
- ;;=MUSCULOSKELETAL DISORDER^10^21
- ;;^UTILITY(U,$J,358.4,188,0)
- ;;=NEUROLOGICAL^12^21
- ;;^UTILITY(U,$J,358.4,189,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^17^21
- ;;^UTILITY(U,$J,358.4,190,0)
- ;;=ESTABLISHED PATIENT^1^22
- ;;^UTILITY(U,$J,358.4,191,0)
- ;;=NEW PATIENT^2^22
- ;;^UTILITY(U,$J,358.4,192,0)
- ;;=NEW PATIENT^2^24
- ;;^UTILITY(U,$J,358.4,193,0)
- ;;=ESTABLISHED PATIENT^1^24
- ;;^UTILITY(U,$J,358.4,194,0)
- ;;=CONSULTATIONS^3^24
- ;;^UTILITY(U,$J,358.4,195,0)
- ;;=POST-OP FOLLOW-UP^4^24
- ;;^UTILITY(U,$J,358.4,196,0)
- ;;=DEBRIDEMENT^2^25
- ;;^UTILITY(U,$J,358.4,197,0)
- ;;=DESTR-BENIGN/PREMALIGNANT^6^25
- ;;^UTILITY(U,$J,358.4,198,0)
- ;;=DEST MAL LESION-TRUNK,ARMS,LEGS^5^25
- ;;^UTILITY(U,$J,358.4,199,0)
- ;;=EXC-BEN LESION-TRUNK,ARM,LEG^10^25
- ;;^UTILITY(U,$J,358.4,200,0)
- ;;=EXC-MAL LESION-TRUNK,ARM,LEG^13^25
- ;;^UTILITY(U,$J,358.4,201,0)
- ;;=INCISION & DRAINAGE^15^25
- ;;^UTILITY(U,$J,358.4,202,0)
- ;;=MISCELLANEOUS^18^25
- ;;^UTILITY(U,$J,358.4,203,0)
- ;;=NAILS^20^25
- ;;^UTILITY(U,$J,358.4,204,0)
- ;;=SHAVING-EPIDERMAL-TRUNK,ARM,LEG^34^25
- ;;^UTILITY(U,$J,358.4,205,0)
- ;;=REPAIR-SIMPLE-SCALP,NK,TRUNK^31^25
- ;;^UTILITY(U,$J,358.4,206,0)
- ;;=REPAIR-INTERM-SCALP,TRUNK^29^25
- ;;^UTILITY(U,$J,358.4,207,0)
- ;;=DEST MAL LES-SCALP,NK,HAND,FEET,GENITALS^4^25
- ;;^UTILITY(U,$J,358.4,208,0)
- ;;=DEST MAL LESION-FACE,MUCOUS^3^25
- ;;^UTILITY(U,$J,358.4,209,0)
- ;;=EXC-BEN LESION-SCALP,HANDS,FT,GENITALS^9^25
- ;;^UTILITY(U,$J,358.4,210,0)
- ;;=EXC-BEN LESION-FACE,MUCOUS^8^25
- ;;^UTILITY(U,$J,358.4,211,0)
- ;;=EXC-MAL LESION-SCALP,NK,HAND,FT,GENITALS^12^25
- ;;^UTILITY(U,$J,358.4,212,0)
- ;;=EXC-MAL LESION-FACE,MUCOUS^11^25
- ;;^UTILITY(U,$J,358.4,213,0)
- ;;=SHAVING-EPIDERM-SCALP,NK,HAND,FT,GENITAL^33^25
- ;;^UTILITY(U,$J,358.4,214,0)
- ;;=SHAVING-EPIDERM-FACE,MUCOUS^32^25
- ;;^UTILITY(U,$J,358.4,215,0)
- ;;=REPAIR-SIMPLE-FACE,MUCOUS^30^25
- ;;^UTILITY(U,$J,358.4,216,0)
- ;;=REPAIR-INTERM-NK,HAND,FT,GENITALIA^28^25
- ;;^UTILITY(U,$J,358.4,217,0)
- ;;=REPAIR-INTERM-FACE,MUCOUS^27^25
- ;;^UTILITY(U,$J,358.4,218,0)
- ;;=WOUND HEALING^42^25
- ;;^UTILITY(U,$J,358.4,219,0)
- ;;=SKIN TEST^36^25
- ;;^UTILITY(U,$J,358.4,220,0)
- ;;=MICROBIOLOGY^17^25
- ;;^UTILITY(U,$J,358.4,221,0)
- ;;=MOHS CHEMOSURGERY^19^25
- ;;^UTILITY(U,$J,358.4,222,0)
- ;;=INJECTIONS^16^25
- ;;^UTILITY(U,$J,358.4,223,0)
- ;;=PEEL^21^25
- ;;^UTILITY(U,$J,358.4,224,0)
- ;;=PHOTOTHERAPY^22^25
- ;;^UTILITY(U,$J,358.4,225,0)
- ;;=REPAIR-COMPLEX-FACE^23^25
- ;;^UTILITY(U,$J,358.4,226,0)
- ;;=REPAIR-COMPLEX-NK/HAND/FT^24^25
- ;;^UTILITY(U,$J,358.4,227,0)
- ;;=REPAIR-COMPLEX-TRUNK^26^25
- ;;^UTILITY(U,$J,358.4,228,0)
- ;;=TISSUE REARRANGMNT-FACE/NECK/HAND/FOOT^39^25
- ;;^UTILITY(U,$J,358.4,229,0)
- ;;=TISSUE REARRANGMNT-SCALP/ARMS/LEGS^40^25
- ;;^UTILITY(U,$J,358.4,230,0)
- ;;=TISSUE REARRANGMNT-TRUNK^41^25
- ;;^UTILITY(U,$J,358.4,231,0)
- ;;=REPAIR-COMPLEX-SCALP^25^25
- ;;^UTILITY(U,$J,358.4,232,0)
- ;;=TISSUE REARRANGMNT-EYELID/NOSE/EAR/LIP^38^25
- ;;^UTILITY(U,$J,358.4,233,0)
- ;;=BIOPSY^1^25
- ;;^UTILITY(U,$J,358.4,234,0)
- ;;=TISSUE REARRANGEMENT-ANY AREA^37^25
- ;;^UTILITY(U,$J,358.4,235,0)
- ;;=SKIN GRAFT/AUTOGRAFT^35^25
- ;;^UTILITY(U,$J,358.4,236,0)
- ;;=DESTR-CUT VASC PROLIFERATION^7^25
- ;;^UTILITY(U,$J,358.4,237,0)
- ;;=FINE NEEDLE ASPIRATION BIOPSY^14^25
- ;;^UTILITY(U,$J,358.4,238,0)
- ;;=A DIAGNOSES^2^26
- ;;^UTILITY(U,$J,358.4,239,0)
- ;;=D DIAGNOSES^5^26
- ;;^UTILITY(U,$J,358.4,240,0)
- ;;=E DIAGNOSES^6^26
- ;;^UTILITY(U,$J,358.4,241,0)
- ;;=F DIAGNOSES^7^26
- ;;^UTILITY(U,$J,358.4,242,0)
- ;;=I DIAGNOSES^10^26
- ;;^UTILITY(U,$J,358.4,243,0)
- ;;=K DIAGNOSES^11^26
- ;;^UTILITY(U,$J,358.4,244,0)
- ;;=M DIAGNOSES^13^26
- ;;^UTILITY(U,$J,358.4,245,0)
- ;;=N DIAGNOSES^14^26
- ;;^UTILITY(U,$J,358.4,246,0)
- ;;=P DIAGNOSES^16^26
- ;;^UTILITY(U,$J,358.4,247,0)
- ;;=R DIAGNOSES^17^26
- ;;^UTILITY(U,$J,358.4,248,0)
- ;;=S DIAGNOSES^18^26
- ;;^UTILITY(U,$J,358.4,249,0)
- ;;=T DIAGNOSES^20^26
- ;;^UTILITY(U,$J,358.4,250,0)
- ;;=V DIAGNOSES^22^26
- ;;^UTILITY(U,$J,358.4,251,0)
- ;;=X DIAGNOSES^24^26
- ;;^UTILITY(U,$J,358.4,252,0)
- ;;=C DIAGNOSES^4^26
- ;;^UTILITY(U,$J,358.4,253,0)
- ;;=W DIAGNOSES^23^26
- ;;^UTILITY(U,$J,358.4,254,0)
- ;;=B DIAGNOSES^3^26
- ;;^UTILITY(U,$J,358.4,255,0)
- ;;=G DIAGNOSES^8^26
- ;;^UTILITY(U,$J,358.4,256,0)
- ;;=H DIAGNOSES^8^26
- ;;^UTILITY(U,$J,358.4,257,0)
- ;;=L DIAGNOSES^12^26
- ;;^UTILITY(U,$J,358.4,258,0)
- ;;=O DIAGNOSES^15^26
- ;;^UTILITY(U,$J,358.4,259,0)
- ;;=U DIAGNOSES^21^26
- ;;^UTILITY(U,$J,358.4,260,0)
- ;;=Z DIAGNOSES^25^26
- ;;^UTILITY(U,$J,358.4,261,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^19^26
- ;;^UTILITY(U,$J,358.4,262,0)
- ;;=MOST COMMON DX^1^26
- ;;^UTILITY(U,$J,358.4,263,0)
- ;;=NEW PATIENT^3^27
- ;;^UTILITY(U,$J,358.4,264,0)
- ;;=ESTABLISHED PATIENT^1^27
- ;;^UTILITY(U,$J,358.4,265,0)
- ;;=CONSULTATIONS^2^27
- ;;^UTILITY(U,$J,358.4,266,0)
- ;;=PREVENTIVE MEDICINE-EST PT^4^27
- ;;^UTILITY(U,$J,358.4,267,0)
- ;;=PREVENTIVE MEDICINE-NEW PT^5^27
- ;;^UTILITY(U,$J,358.4,268,0)
- ;;=RISK FACTOR REDUCTION-GRP^6^27
- ;;^UTILITY(U,$J,358.4,269,0)
- ;;=RISK FACTOR REDUCTION-IND^7^27
- ;;^UTILITY(U,$J,358.4,270,0)
- ;;=OTHER^3^28
- ;;^UTILITY(U,$J,358.4,271,0)
- ;;=EDUCATION/TRAINING^1^28
- ;;^UTILITY(U,$J,358.4,272,0)
- ;;=MEDICAL NUTRITION THERAPY^2^28
- ;;^UTILITY(U,$J,358.4,273,0)
- ;;=WOUND TREATMENT^5^28
- ;;^UTILITY(U,$J,358.4,274,0)
- ;;=PROLONGED SERVICES^4^28
- ;;^UTILITY(U,$J,358.4,275,0)
- ;;=DIABETES^1^29
- ;;^UTILITY(U,$J,358.4,276,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^2^29
- ;;^UTILITY(U,$J,358.4,277,0)
- ;;=NEW PATIENT^2^30
- ;;^UTILITY(U,$J,358.4,278,0)
- ;;=ESTABLISHED PATIENT^1^30
- ;;^UTILITY(U,$J,358.4,279,0)
- ;;=CONSULTATIONS^3^30
- ;;^UTILITY(U,$J,358.4,280,0)
- ;;=ENDOCRINE DX^1^31
- ;;^UTILITY(U,$J,358.4,281,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^2^31
- ;;^UTILITY(U,$J,358.4,282,0)
- ;;=BIOPSIES^1^32
- ;;^UTILITY(U,$J,358.4,283,0)
- ;;=INJECTIONS & INFUSIONS^2^32
- ;;^UTILITY(U,$J,358.4,284,0)
- ;;=OTHER^4^32
- ;;^UTILITY(U,$J,358.4,285,0)
- ;;=PROLONGED CLINICAL STAFF SERVICES^5^32
- ;;^UTILITY(U,$J,358.4,286,0)
- ;;=LAB TESTS^3^32
- ;;^UTILITY(U,$J,358.4,287,0)
- ;;=NEW PATIENT^3^33
- ;;^UTILITY(U,$J,358.4,288,0)
- ;;=ESTABLISHED PATIENT^2^33
- ;;^UTILITY(U,$J,358.4,289,0)
- ;;=CONSULTS - OUTPT^4^33
- ;;^UTILITY(U,$J,358.4,290,0)
- ;;=EYE CODES^1^33
- ;;^UTILITY(U,$J,358.4,291,0)
- ;;=CONSULTS - INPT^5^33
- ;;^UTILITY(U,$J,358.4,292,0)
- ;;=HOSPITAL CARE - INITIAL^6^33
- ;;^UTILITY(U,$J,358.4,293,0)
- ;;=HOSPITAL CARE - SUBSEQUENT^7^33
- ;;^UTILITY(U,$J,358.4,294,0)
- ;;=HOSPITAL CARE - DISCHARGE^8^33
- ;;^UTILITY(U,$J,358.4,295,0)
- ;;=OBSERVATION CARE - INITIAL^9^33
- ;;^UTILITY(U,$J,358.4,296,0)
- ;;=OBSERVATION CARE - SUBSEQUENT^10^33
- ;;^UTILITY(U,$J,358.4,297,0)
- ;;=OBSERVATION CARE - DISCHARGE^11^33
- ;;^UTILITY(U,$J,358.4,298,0)
- ;;=INPT or OBS - ADMIT & DISCHARGE SAME DAY^12^33
- ;;^UTILITY(U,$J,358.4,299,0)
- ;;=EEF Version 2022 April^13^33
- ;;^UTILITY(U,$J,358.4,300,0)
- ;;=PROC - LID / LACRIMAL^7^34
- ;;^UTILITY(U,$J,358.4,301,0)
- ;;=PROC - LASER / CRYO^10^34
- ;;^UTILITY(U,$J,358.4,302,0)
- ;;=PROC - CORNEA / CONJ^6^34
- ;;^UTILITY(U,$J,358.4,303,0)
- ;;=MEDICATIONS^12^34
- ;;^UTILITY(U,$J,358.4,304,0)
- ;;=PROC - INJECTIONS / ALL^9^34
- ;;^UTILITY(U,$J,358.4,305,0)
- ;;=IMAGE / PHOTOS^2^34
- ;;^UTILITY(U,$J,358.4,306,0)
- ;;=REFRACT / GLASSES / CL^1^34
- ;;^UTILITY(U,$J,358.4,307,0)
- ;;=TEST - CATARACT / CORNEA^4^34
- ;;^UTILITY(U,$J,358.4,308,0)
- ;;=TEST - GLAUCOMA^3^34
- ;;^UTILITY(U,$J,358.4,309,0)
- ;;=TEST - OTHER^5^34
- ;;^UTILITY(U,$J,358.4,310,0)
- ;;=EDUCATION / COUNSELING^13^34
- ;;^UTILITY(U,$J,358.4,311,0)
- ;;=EYE SURGERY CODES^11^34
- ;;^UTILITY(U,$J,358.4,312,0)
- ;;=PROC - INJECTIONS / VEGF^8^34
- ;;^UTILITY(U,$J,358.4,313,0)
- ;;=TEST - ERG / VEP^14^34
- ;;^UTILITY(U,$J,358.4,314,0)
- ;;=LOW VISION / BLINDNESS^21^35
- ;;^UTILITY(U,$J,358.4,315,0)
- ;;=RETINA - VASCULAR^12^35
- ;;^UTILITY(U,$J,358.4,316,0)
- ;;=EYELIDS / LASHES^2^35
- ;;^UTILITY(U,$J,358.4,317,0)
- ;;=NEURO / STRABISMUS^18^35
- ;;^UTILITY(U,$J,358.4,318,0)
- ;;=ORBIT - PLASTICS^20^35
- ;;^UTILITY(U,$J,358.4,319,0)
- ;;=VITREOUS^17^35
- ;;^UTILITY(U,$J,358.4,320,0)
- ;;=ORBIT - TRAUMA^19^35
- ;;^UTILITY(U,$J,358.4,321,0)
- ;;=LACRIMAL / NLD / NEOPLASMS^3^35
- ;;^UTILITY(U,$J,358.4,322,0)
- ;;=MOST FREQUENT^1^35
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0FN 19769 printed Jan 18, 2025@02:48:59 Page 2
- IBDEI0FN ; ; 03-MAY-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
- +2 if 'DIFQR(358.4)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.4)
- +2 ;;=^IBE(358.4,
- +3 ;;^UTILITY(U,$J,358.4,0)
- +4 ;;=IMP/EXP SELECTION GROUP^358.4I^1536^1504
- +5 ;;^UTILITY(U,$J,358.4,1,0)
- +6 ;;=NEW PATIENT^2^1
- +7 ;;^UTILITY(U,$J,358.4,2,0)
- +8 ;;=ESTABLISHED PATIENT^1^1
- +9 ;;^UTILITY(U,$J,358.4,3,0)
- +10 ;;=CONSULTATIONS^3^1
- +11 ;;^UTILITY(U,$J,358.4,4,0)
- +12 ;;=ALLERGY DIAGNOSES^1^2
- +13 ;;^UTILITY(U,$J,358.4,5,0)
- +14 ;;=IMMUNODEFICIENCY^2^2
- +15 ;;^UTILITY(U,$J,358.4,6,0)
- +16 ;;=OTHER^3^2
- +17 ;;^UTILITY(U,$J,358.4,7,0)
- +18 ;;=IMMUNIZATION^4^3
- +19 ;;^UTILITY(U,$J,358.4,8,0)
- +20 ;;=SKIN TEST^9^3
- +21 ;;^UTILITY(U,$J,358.4,9,0)
- +22 ;;=ALLERGENIC EXTRACT^1^3
- +23 ;;^UTILITY(U,$J,358.4,10,0)
- +24 ;;=PATCH TESTS^8^3
- +25 ;;^UTILITY(U,$J,358.4,11,0)
- +26 ;;=ALLERGY INJECTION/EXTRACT^2^3
- +27 ;;^UTILITY(U,$J,358.4,12,0)
- +28 ;;=LABORATORY^6^3
- +29 ;;^UTILITY(U,$J,358.4,13,0)
- +30 ;;=INFUSIONS^5^3
- +31 ;;^UTILITY(U,$J,358.4,14,0)
- +32 ;;=OTHER^7^3
- +33 ;;^UTILITY(U,$J,358.4,15,0)
- +34 ;;=EDUCATION/TRAINING^1^4
- +35 ;;^UTILITY(U,$J,358.4,16,0)
- +36 ;;=FAMILY TRAINING-GROUP^2^4
- +37 ;;^UTILITY(U,$J,358.4,17,0)
- +38 ;;=PROCEDURE CODES-GROUP^3^4
- +39 ;;^UTILITY(U,$J,358.4,18,0)
- +40 ;;=RECREATION THERAPY DX^1^5
- +41 ;;^UTILITY(U,$J,358.4,19,0)
- +42 ;;=SDOH^2^5
- +43 ;;^UTILITY(U,$J,358.4,20,0)
- +44 ;;=1-1 THERAPEUTIC PROCEDURES^1^6
- +45 ;;^UTILITY(U,$J,358.4,21,0)
- +46 ;;=EDUCATION/TRAINING^3^6
- +47 ;;^UTILITY(U,$J,358.4,22,0)
- +48 ;;=TEAM CONFERENCE^6^6
- +49 ;;^UTILITY(U,$J,358.4,23,0)
- +50 ;;=ASSESSMENT^2^6
- +51 ;;^UTILITY(U,$J,358.4,24,0)
- +52 ;;=FAMILY TRAINING^4^6
- +53 ;;^UTILITY(U,$J,358.4,25,0)
- +54 ;;=SPECIALTY PROCEDURES-INDIVIDUAL^5^6
- +55 ;;^UTILITY(U,$J,358.4,26,0)
- +56 ;;=RECREATION THERAPY DX^1^7
- +57 ;;^UTILITY(U,$J,358.4,27,0)
- +58 ;;=SDOH^2^7
- +59 ;;^UTILITY(U,$J,358.4,28,0)
- +60 ;;=SPECIAL SERVICES^10^8
- +61 ;;^UTILITY(U,$J,358.4,29,0)
- +62 ;;=CHEMO NURSE PROCEDURES^2^8
- +63 ;;^UTILITY(U,$J,358.4,30,0)
- +64 ;;=INFUSION DRUGS^7^8
- +65 ;;^UTILITY(U,$J,358.4,31,0)
- +66 ;;=BLOOD PRODUCTS^1^8
- +67 ;;^UTILITY(U,$J,358.4,32,0)
- +68 ;;=DIAGNOSTIC PROCEDURES^3^8
- +69 ;;^UTILITY(U,$J,358.4,33,0)
- +70 ;;=OTHER DRUGS^8^8
- +71 ;;^UTILITY(U,$J,358.4,34,0)
- +72 ;;=IMMUNIZATION ADMINISTRATION^5^8
- +73 ;;^UTILITY(U,$J,358.4,35,0)
- +74 ;;=IMMUNIZATIONS^6^8
- +75 ;;^UTILITY(U,$J,358.4,36,0)
- +76 ;;=PROLONGED SVC-MD/NP/PA^9^8
- +77 ;;^UTILITY(U,$J,358.4,37,0)
- +78 ;;=EDUCATION/TRAINING^4^8
- +79 ;;^UTILITY(U,$J,358.4,38,0)
- +80 ;;=NEW PATIENT^2^9
- +81 ;;^UTILITY(U,$J,358.4,39,0)
- +82 ;;=ESTABLISHED PATIENT^1^9
- +83 ;;^UTILITY(U,$J,358.4,40,0)
- +84 ;;=CONSULTATIONS^3^9
- +85 ;;^UTILITY(U,$J,358.4,41,0)
- +86 ;;=COMPLEX CHRONIC CARE^4^9
- +87 ;;^UTILITY(U,$J,358.4,42,0)
- +88 ;;=ANEMIA^1^10
- +89 ;;^UTILITY(U,$J,358.4,43,0)
- +90 ;;=ARTIFICIAL OPENING STATUS^2^10
- +91 ;;^UTILITY(U,$J,358.4,44,0)
- +92 ;;=BREASTS and GYN NEOPLASMS^3^10
- +93 ;;^UTILITY(U,$J,358.4,45,0)
- +94 ;;=COAGULATION DISORDERS^4^10
- +95 ;;^UTILITY(U,$J,358.4,46,0)
- +96 ;;=COUNSELING AND SCREENING^5^10
- +97 ;;^UTILITY(U,$J,358.4,47,0)
- +98 ;;=GENITOURINARY NEOPLASMS^6^10
- +99 ;;^UTILITY(U,$J,358.4,48,0)
- +100 ;;=GI CANCER^7^10
- +101 ;;^UTILITY(U,$J,358.4,49,0)
- +102 ;;=HEAD NECK AND LUNGS NEOPLASMS^8^10
- +103 ;;^UTILITY(U,$J,358.4,50,0)
- +104 ;;=HEMOGLOBINOPATHIES^9^10
- +105 ;;^UTILITY(U,$J,358.4,51,0)
- +106 ;;=LYMPHOID NEOPLASMS^10^10
- +107 ;;^UTILITY(U,$J,358.4,52,0)
- +108 ;;=METASTATIC SITES^13^10
- +109 ;;^UTILITY(U,$J,358.4,53,0)
- +110 ;;=MALIGNANT NEOPLASMS OF OTHER SITES^11^10
- +111 ;;^UTILITY(U,$J,358.4,54,0)
- +112 ;;=MYELOID NEOPLASMS AND DISORDERS^14^10
- +113 ;;^UTILITY(U,$J,358.4,55,0)
- +114 ;;=NEOPLASM OF UNCERTAIN BEHAVIOR^15^10
- +115 ;;^UTILITY(U,$J,358.4,56,0)
- +116 ;;=NEOPLASM OF UNSPECIFIED NATURE^16^10
- +117 ;;^UTILITY(U,$J,358.4,57,0)
- +118 ;;=PERSONAL HISTORY^19^10
- +119 ;;^UTILITY(U,$J,358.4,58,0)
- +120 ;;=MALNUTRITION^12^10
- +121 ;;^UTILITY(U,$J,358.4,59,0)
- +122 ;;=OTHER^18^10
- +123 ;;^UTILITY(U,$J,358.4,60,0)
- +124 ;;=SUICIDE IDEATIONS/ATTEMPTS^20^10
- +125 ;;^UTILITY(U,$J,358.4,61,0)
- +126 ;;=ESTABLISHED PATIENT^1^11
- +127 ;;^UTILITY(U,$J,358.4,62,0)
- +128 ;;=CARE PLAN OVERSIGHT^1^12
- +129 ;;^UTILITY(U,$J,358.4,63,0)
- +130 ;;=OTHER SERVICES^4^12
- +131 ;;^UTILITY(U,$J,358.4,64,0)
- +132 ;;=CASE MANAGEMENT^2^12
- +133 ;;^UTILITY(U,$J,358.4,65,0)
- +134 ;;=EDUCATION^3^12
- +135 ;;^UTILITY(U,$J,358.4,66,0)
- +136 ;;=CARDIOVASCULAR DISORDERS^1^13
- +137 ;;^UTILITY(U,$J,358.4,67,0)
- +138 ;;=CONDITIONS AFFECTING HEALTH CARE STATUS^2^13
- +139 ;;^UTILITY(U,$J,358.4,68,0)
- +140 ;;=DIABETES^4^13
- +141 ;;^UTILITY(U,$J,358.4,69,0)
- +142 ;;=EYE & EAR DISORDERS^4^13
- +143 ;;^UTILITY(U,$J,358.4,70,0)
- +144 ;;=MENTAL HEALTH^5^13
- +145 ;;^UTILITY(U,$J,358.4,71,0)
- +146 ;;=NEOPLASMS^6^13
- +147 ;;^UTILITY(U,$J,358.4,72,0)
- +148 ;;=NEUROLOGICAL CONDITIONS^7^13
- +149 ;;^UTILITY(U,$J,358.4,73,0)
- +150 ;;=OTHER CONDITIONS^8^13
- +151 ;;^UTILITY(U,$J,358.4,74,0)
- +152 ;;=RESPIRATORY DISORDERS^9^13
- +153 ;;^UTILITY(U,$J,358.4,75,0)
- +154 ;;=DEMENTIA^3^13
- +155 ;;^UTILITY(U,$J,358.4,76,0)
- +156 ;;=ACOUSTIC NERVE INJURIES^1^14
- +157 ;;^UTILITY(U,$J,358.4,77,0)
- +158 ;;=AUDITORY DISORDERS^2^14
- +159 ;;^UTILITY(U,$J,358.4,78,0)
- +160 ;;=BALANCE DISORDERS^3^14
- +161 ;;^UTILITY(U,$J,358.4,79,0)
- +162 ;;=BAROTRAUMA^4^14
- +163 ;;^UTILITY(U,$J,358.4,80,0)
- +164 ;;=EAR DISEASE^5^14
- +165 ;;^UTILITY(U,$J,358.4,81,0)
- +166 ;;=FOREIGN BODIES^7^14
- +167 ;;^UTILITY(U,$J,358.4,82,0)
- +168 ;;=HEARING LOSS^8^14
- +169 ;;^UTILITY(U,$J,358.4,83,0)
- +170 ;;=NOISE INJURIES^9^14
- +171 ;;^UTILITY(U,$J,358.4,84,0)
- +172 ;;=NYSTAGMUS^10^14
- +173 ;;^UTILITY(U,$J,358.4,85,0)
- +174 ;;=OTOTOXICITY^11^14
- +175 ;;^UTILITY(U,$J,358.4,86,0)
- +176 ;;=PURPOSE OF ENCOUNTER/HEALTH STATUS^12^14
- +177 ;;^UTILITY(U,$J,358.4,87,0)
- +178 ;;=EXTERNAL EAR DISEASES^6^14
- +179 ;;^UTILITY(U,$J,358.4,88,0)
- +180 ;;=NEW PATIENT^2^15
- +181 ;;^UTILITY(U,$J,358.4,89,0)
- +182 ;;=ESTABLISHED PATIENT^1^15
- +183 ;;^UTILITY(U,$J,358.4,90,0)
- +184 ;;=CONSULTATIONS^3^15
- +185 ;;^UTILITY(U,$J,358.4,91,0)
- +186 ;;=AUDIOLOGIC FUNCTION TESTS^1^16
- +187 ;;^UTILITY(U,$J,358.4,92,0)
- +188 ;;=SCREENING^13^16
- +189 ;;^UTILITY(U,$J,358.4,93,0)
- +190 ;;=COCHLEAR IMPLANT^3^16
- +191 ;;^UTILITY(U,$J,358.4,94,0)
- +192 ;;=OTHER TREATMENT^10^16
- +193 ;;^UTILITY(U,$J,358.4,95,0)
- +194 ;;=DISPENSING^5^16
- +195 ;;^UTILITY(U,$J,358.4,96,0)
- +196 ;;=REMOVAL FOREIGN BODY/CERUMEN^12^16
- +197 ;;^UTILITY(U,$J,358.4,97,0)
- +198 ;;=VESTIBULAR FUNCT W/ RECORDING^15^16
- +199 ;;^UTILITY(U,$J,358.4,98,0)
- +200 ;;=VESTIBULAR FUNCT W/O RECORDING^16^16
- +201 ;;^UTILITY(U,$J,358.4,99,0)
- +202 ;;=EVALUATIVE & THERAPEUTIC SVCS^6^16
- +203 ;;^UTILITY(U,$J,358.4,100,0)
- +204 ;;=TEAM CONFERENCE^14^16
- +205 ;;^UTILITY(U,$J,358.4,101,0)
- +206 ;;=PROLONGED CLINICAL STAFF SERVICES^11^16
- +207 ;;^UTILITY(U,$J,358.4,102,0)
- +208 ;;=OTHER SERVICES^9^16
- +209 ;;^UTILITY(U,$J,358.4,103,0)
- +210 ;;=DEVICES & EQUIPMENT^4^16
- +211 ;;^UTILITY(U,$J,358.4,104,0)
- +212 ;;=EXCISION^7^16
- +213 ;;^UTILITY(U,$J,358.4,105,0)
- +214 ;;=INCISION^8^16
- +215 ;;^UTILITY(U,$J,358.4,106,0)
- +216 ;;=AUTOMATED AUDIOMETRY^2^16
- +217 ;;^UTILITY(U,$J,358.4,107,0)
- +218 ;;=NEW PATIENT^2^17
- +219 ;;^UTILITY(U,$J,358.4,108,0)
- +220 ;;=ESTABLISHED PATIENT^1^17
- +221 ;;^UTILITY(U,$J,358.4,109,0)
- +222 ;;=CONSULTATIONS^3^17
- +223 ;;^UTILITY(U,$J,358.4,110,0)
- +224 ;;=ARRHYTHMIA^3^18
- +225 ;;^UTILITY(U,$J,358.4,111,0)
- +226 ;;=CHEST PAIN^4^18
- +227 ;;^UTILITY(U,$J,358.4,112,0)
- +228 ;;=CHF/MYOPATHY/TRANSPLANT^5^18
- +229 ;;^UTILITY(U,$J,358.4,113,0)
- +230 ;;=CORONARY ATHEROSCLEROSIS^6^18
- +231 ;;^UTILITY(U,$J,358.4,114,0)
- +232 ;;=GENERAL SYMPTOMS^9^18
- +233 ;;^UTILITY(U,$J,358.4,115,0)
- +234 ;;=HISTORY^12^18
- +235 ;;^UTILITY(U,$J,358.4,116,0)
- +236 ;;=HYPERTENSION/HYPOTENSION^13^18
- +237 ;;^UTILITY(U,$J,358.4,117,0)
- +238 ;;=INFECTION/INFLM DISEASE^14^18
- +239 ;;^UTILITY(U,$J,358.4,118,0)
- +240 ;;=LIPID DISORDER^15^18
- +241 ;;^UTILITY(U,$J,358.4,119,0)
- +242 ;;=MYOCARDIAL INFARCTION^17^18
- +243 ;;^UTILITY(U,$J,358.4,120,0)
- +244 ;;=NONRHEUMATIC HEART VALVE DISORDERS^18^18
- +245 ;;^UTILITY(U,$J,358.4,121,0)
- +246 ;;=HEART DISEASE^10^18
- +247 ;;^UTILITY(U,$J,358.4,122,0)
- +248 ;;=HEART VALVE DISEASE^11^18
- +249 ;;^UTILITY(U,$J,358.4,123,0)
- +250 ;;=PERIPHERAL VASC DISEASE^20^18
- +251 ;;^UTILITY(U,$J,358.4,124,0)
- +252 ;;=RHEUMATIC HEART DISEASE^23^18
- +253 ;;^UTILITY(U,$J,358.4,125,0)
- +254 ;;=DEVICE/IMPLANT/GRAFT^7^18
- +255 ;;^UTILITY(U,$J,358.4,126,0)
- +256 ;;=SYNCOPE^26^18
- +257 ;;^UTILITY(U,$J,358.4,127,0)
- +258 ;;=SUICIDE IDEATIONS/ATTEMPTS^24^18
- +259 ;;^UTILITY(U,$J,358.4,128,0)
- +260 ;;=ECTOPY^8^18
- +261 ;;^UTILITY(U,$J,358.4,129,0)
- +262 ;;=MISCELLANEOUS^16^18
- +263 ;;^UTILITY(U,$J,358.4,130,0)
- +264 ;;=VENTRICULAR ARRHYTHMIAS^27^18
- +265 ;;^UTILITY(U,$J,358.4,131,0)
- +266 ;;=SUPRAVENTRICULAR ARRHYTHMIAS^25^18
- +267 ;;^UTILITY(U,$J,358.4,132,0)
- +268 ;;=OTHER CARDIAC CONDITIONS^22^18
- +269 ;;^UTILITY(U,$J,358.4,133,0)
- +270 ;;=PULMONARY DISEASE^21^18
- +271 ;;^UTILITY(U,$J,358.4,134,0)
- +272 ;;=PACEMAKER/AIC/DEFIBRILLATOR^19^18
- +273 ;;^UTILITY(U,$J,358.4,135,0)
- +274 ;;=ACSC CHF^1^18
- +275 ;;^UTILITY(U,$J,358.4,136,0)
- +276 ;;=ACSC HYPERTENSION^2^18
- +277 ;;^UTILITY(U,$J,358.4,137,0)
- +278 ;;=PACEMAKER^15^19
- +279 ;;^UTILITY(U,$J,358.4,138,0)
- +280 ;;=CORONARY ANGIOPLASTY & STENTS^3^19
- +281 ;;^UTILITY(U,$J,358.4,139,0)
- +282 ;;=ELECTROPHYSIOLOGICAL PROCs^7^19
- +283 ;;^UTILITY(U,$J,358.4,140,0)
- +284 ;;=PERIPHERAL ANGIOPLASTIES & STENTS^16^19
- +285 ;;^UTILITY(U,$J,358.4,141,0)
- +286 ;;=VASCULAR INJECTION PROCs^21^19
- +287 ;;^UTILITY(U,$J,358.4,142,0)
- +288 ;;=OTHER PROCEDURES^14^19
- +289 ;;^UTILITY(U,$J,358.4,143,0)
- +290 ;;=HEART CATHETERIZATIONS^8^19
- +291 ;;^UTILITY(U,$J,358.4,144,0)
- +292 ;;=CATHETERIZATIONS FOR INT RADIOLOGY^2^19
- +293 ;;^UTILITY(U,$J,358.4,145,0)
- +294 ;;=OTHER HEART CODES^13^19
- +295 ;;^UTILITY(U,$J,358.4,146,0)
- +296 ;;=PROSTHETIC ANEURYSM REPAIR^19^19
- +297 ;;^UTILITY(U,$J,358.4,147,0)
- +298 ;;=DEVICE PROGRAMMING^4^19
- +299 ;;^UTILITY(U,$J,358.4,148,0)
- +300 ;;=ECHO^5^19
- +301 ;;^UTILITY(U,$J,358.4,149,0)
- +302 ;;=EKG^6^19
- +303 ;;^UTILITY(U,$J,358.4,150,0)
- +304 ;;=MEDICATION ADMINISTRATION^9^19
- +305 ;;^UTILITY(U,$J,358.4,151,0)
- +306 ;;=MEDICATIONS^10^19
- +307 ;;^UTILITY(U,$J,358.4,152,0)
- +308 ;;=OTHER CARDIAC^12^19
- +309 ;;^UTILITY(U,$J,358.4,153,0)
- +310 ;;=STRESS TESTS^20^19
- +311 ;;^UTILITY(U,$J,358.4,154,0)
- +312 ;;=PREVENTIVE COUNSELING^17^19
- +313 ;;^UTILITY(U,$J,358.4,155,0)
- +314 ;;=MODERATE SEDATION (MS)^11^19
- +315 ;;^UTILITY(U,$J,358.4,156,0)
- +316 ;;=VENTRICULAR ASSIST DEVICE INSERTION^22^19
- +317 ;;^UTILITY(U,$J,358.4,157,0)
- +318 ;;=CARDIOVERSION^1^19
- +319 ;;^UTILITY(U,$J,358.4,158,0)
- +320 ;;=PROLONGED SERVICES^18^19
- +321 ;;^UTILITY(U,$J,358.4,159,0)
- +322 ;;=COUNSELING/EDUCATION^5^20
- +323 ;;^UTILITY(U,$J,358.4,160,0)
- +324 ;;=PSYCHIATRIC THERAPY^10^20
- +325 ;;^UTILITY(U,$J,358.4,161,0)
- +326 ;;=BIOFEEDBACK THERAPY^2^20
- +327 ;;^UTILITY(U,$J,358.4,162,0)
- +328 ;;=BIOPSYCHOSOCIAL ASSESS/INTERVENTION^3^20
- +329 ;;^UTILITY(U,$J,358.4,163,0)
- +330 ;;=PHYSICAL THERAPY^9^20
- +331 ;;^UTILITY(U,$J,358.4,164,0)
- +332 ;;=OTHER THERAPEUTIC TECHNIQUES^8^20
- +333 ;;^UTILITY(U,$J,358.4,165,0)
- +334 ;;=ACUPUNTURE^1^20
- +335 ;;^UTILITY(U,$J,358.4,166,0)
- +336 ;;=OSTEOPATHIC MANIPULATION^7^20
- +337 ;;^UTILITY(U,$J,358.4,167,0)
- +338 ;;=CHIROPRACTIC MANIPULATION^4^20
- +339 ;;^UTILITY(U,$J,358.4,168,0)
- +340 ;;=SELF-MANAGEMENT TRAINING^11^20
- +341 ;;^UTILITY(U,$J,358.4,169,0)
- +342 ;;=NUTRITION APPROACHES^6^20
- +343 ;;^UTILITY(U,$J,358.4,170,0)
- +344 ;;=VA WHOLE HEALTH PARTNER SVCS^12^20
- +345 ;;^UTILITY(U,$J,358.4,171,0)
- +346 ;;=COUNSELING^2^21
- +347 ;;^UTILITY(U,$J,358.4,172,0)
- +348 ;;=HISTORY OF ILLNESS^7^21
- +349 ;;^UTILITY(U,$J,358.4,173,0)
- +350 ;;=OTHER^19^21
- +351 ;;^UTILITY(U,$J,358.4,174,0)
- +352 ;;=SCREENING^14^21
- +353 ;;^UTILITY(U,$J,358.4,175,0)
- +354 ;;=CARDIOVASCULAR DISORDER^1^21
- +355 ;;^UTILITY(U,$J,358.4,176,0)
- +356 ;;=DIABETIC MANAGEMENT^3^21
- +357 ;;^UTILITY(U,$J,358.4,177,0)
- +358 ;;=ENDOCRINE DISORDER^4^21
- +359 ;;^UTILITY(U,$J,358.4,178,0)
- +360 ;;=HEARING DISORDER^6^21
- +361 ;;^UTILITY(U,$J,358.4,179,0)
- +362 ;;=GASTROINTESTINAL DISORDER^5^21
- +363 ;;^UTILITY(U,$J,358.4,180,0)
- +364 ;;=INJURIES^8^21
- +365 ;;^UTILITY(U,$J,358.4,181,0)
- +366 ;;=NEOPLASM^11^21
- +367 ;;^UTILITY(U,$J,358.4,182,0)
- +368 ;;=RESPIRATORY DISORDER^13^21
- +369 ;;^UTILITY(U,$J,358.4,183,0)
- +370 ;;=SIGNS AND SYMPTOMS^15^21
- +371 ;;^UTILITY(U,$J,358.4,184,0)
- +372 ;;=SUBSTANCE DISORDERS^16^21
- +373 ;;^UTILITY(U,$J,358.4,185,0)
- +374 ;;=WEIGHT MANAGEMENT^18^21
- +375 ;;^UTILITY(U,$J,358.4,186,0)
- +376 ;;=MOOD DISORDER^9^21
- +377 ;;^UTILITY(U,$J,358.4,187,0)
- +378 ;;=MUSCULOSKELETAL DISORDER^10^21
- +379 ;;^UTILITY(U,$J,358.4,188,0)
- +380 ;;=NEUROLOGICAL^12^21
- +381 ;;^UTILITY(U,$J,358.4,189,0)
- +382 ;;=SUICIDE IDEATIONS/ATTEMPTS^17^21
- +383 ;;^UTILITY(U,$J,358.4,190,0)
- +384 ;;=ESTABLISHED PATIENT^1^22
- +385 ;;^UTILITY(U,$J,358.4,191,0)
- +386 ;;=NEW PATIENT^2^22
- +387 ;;^UTILITY(U,$J,358.4,192,0)
- +388 ;;=NEW PATIENT^2^24
- +389 ;;^UTILITY(U,$J,358.4,193,0)
- +390 ;;=ESTABLISHED PATIENT^1^24
- +391 ;;^UTILITY(U,$J,358.4,194,0)
- +392 ;;=CONSULTATIONS^3^24
- +393 ;;^UTILITY(U,$J,358.4,195,0)
- +394 ;;=POST-OP FOLLOW-UP^4^24
- +395 ;;^UTILITY(U,$J,358.4,196,0)
- +396 ;;=DEBRIDEMENT^2^25
- +397 ;;^UTILITY(U,$J,358.4,197,0)
- +398 ;;=DESTR-BENIGN/PREMALIGNANT^6^25
- +399 ;;^UTILITY(U,$J,358.4,198,0)
- +400 ;;=DEST MAL LESION-TRUNK,ARMS,LEGS^5^25
- +401 ;;^UTILITY(U,$J,358.4,199,0)
- +402 ;;=EXC-BEN LESION-TRUNK,ARM,LEG^10^25
- +403 ;;^UTILITY(U,$J,358.4,200,0)
- +404 ;;=EXC-MAL LESION-TRUNK,ARM,LEG^13^25
- +405 ;;^UTILITY(U,$J,358.4,201,0)
- +406 ;;=INCISION & DRAINAGE^15^25
- +407 ;;^UTILITY(U,$J,358.4,202,0)
- +408 ;;=MISCELLANEOUS^18^25
- +409 ;;^UTILITY(U,$J,358.4,203,0)
- +410 ;;=NAILS^20^25
- +411 ;;^UTILITY(U,$J,358.4,204,0)
- +412 ;;=SHAVING-EPIDERMAL-TRUNK,ARM,LEG^34^25
- +413 ;;^UTILITY(U,$J,358.4,205,0)
- +414 ;;=REPAIR-SIMPLE-SCALP,NK,TRUNK^31^25
- +415 ;;^UTILITY(U,$J,358.4,206,0)
- +416 ;;=REPAIR-INTERM-SCALP,TRUNK^29^25
- +417 ;;^UTILITY(U,$J,358.4,207,0)
- +418 ;;=DEST MAL LES-SCALP,NK,HAND,FEET,GENITALS^4^25
- +419 ;;^UTILITY(U,$J,358.4,208,0)
- +420 ;;=DEST MAL LESION-FACE,MUCOUS^3^25
- +421 ;;^UTILITY(U,$J,358.4,209,0)
- +422 ;;=EXC-BEN LESION-SCALP,HANDS,FT,GENITALS^9^25
- +423 ;;^UTILITY(U,$J,358.4,210,0)
- +424 ;;=EXC-BEN LESION-FACE,MUCOUS^8^25
- +425 ;;^UTILITY(U,$J,358.4,211,0)
- +426 ;;=EXC-MAL LESION-SCALP,NK,HAND,FT,GENITALS^12^25
- +427 ;;^UTILITY(U,$J,358.4,212,0)
- +428 ;;=EXC-MAL LESION-FACE,MUCOUS^11^25
- +429 ;;^UTILITY(U,$J,358.4,213,0)
- +430 ;;=SHAVING-EPIDERM-SCALP,NK,HAND,FT,GENITAL^33^25
- +431 ;;^UTILITY(U,$J,358.4,214,0)
- +432 ;;=SHAVING-EPIDERM-FACE,MUCOUS^32^25
- +433 ;;^UTILITY(U,$J,358.4,215,0)
- +434 ;;=REPAIR-SIMPLE-FACE,MUCOUS^30^25
- +435 ;;^UTILITY(U,$J,358.4,216,0)
- +436 ;;=REPAIR-INTERM-NK,HAND,FT,GENITALIA^28^25
- +437 ;;^UTILITY(U,$J,358.4,217,0)
- +438 ;;=REPAIR-INTERM-FACE,MUCOUS^27^25
- +439 ;;^UTILITY(U,$J,358.4,218,0)
- +440 ;;=WOUND HEALING^42^25
- +441 ;;^UTILITY(U,$J,358.4,219,0)
- +442 ;;=SKIN TEST^36^25
- +443 ;;^UTILITY(U,$J,358.4,220,0)
- +444 ;;=MICROBIOLOGY^17^25
- +445 ;;^UTILITY(U,$J,358.4,221,0)
- +446 ;;=MOHS CHEMOSURGERY^19^25
- +447 ;;^UTILITY(U,$J,358.4,222,0)
- +448 ;;=INJECTIONS^16^25
- +449 ;;^UTILITY(U,$J,358.4,223,0)
- +450 ;;=PEEL^21^25
- +451 ;;^UTILITY(U,$J,358.4,224,0)
- +452 ;;=PHOTOTHERAPY^22^25
- +453 ;;^UTILITY(U,$J,358.4,225,0)
- +454 ;;=REPAIR-COMPLEX-FACE^23^25
- +455 ;;^UTILITY(U,$J,358.4,226,0)
- +456 ;;=REPAIR-COMPLEX-NK/HAND/FT^24^25
- +457 ;;^UTILITY(U,$J,358.4,227,0)
- +458 ;;=REPAIR-COMPLEX-TRUNK^26^25
- +459 ;;^UTILITY(U,$J,358.4,228,0)
- +460 ;;=TISSUE REARRANGMNT-FACE/NECK/HAND/FOOT^39^25
- +461 ;;^UTILITY(U,$J,358.4,229,0)
- +462 ;;=TISSUE REARRANGMNT-SCALP/ARMS/LEGS^40^25
- +463 ;;^UTILITY(U,$J,358.4,230,0)
- +464 ;;=TISSUE REARRANGMNT-TRUNK^41^25
- +465 ;;^UTILITY(U,$J,358.4,231,0)
- +466 ;;=REPAIR-COMPLEX-SCALP^25^25
- +467 ;;^UTILITY(U,$J,358.4,232,0)
- +468 ;;=TISSUE REARRANGMNT-EYELID/NOSE/EAR/LIP^38^25
- +469 ;;^UTILITY(U,$J,358.4,233,0)
- +470 ;;=BIOPSY^1^25
- +471 ;;^UTILITY(U,$J,358.4,234,0)
- +472 ;;=TISSUE REARRANGEMENT-ANY AREA^37^25
- +473 ;;^UTILITY(U,$J,358.4,235,0)
- +474 ;;=SKIN GRAFT/AUTOGRAFT^35^25
- +475 ;;^UTILITY(U,$J,358.4,236,0)
- +476 ;;=DESTR-CUT VASC PROLIFERATION^7^25
- +477 ;;^UTILITY(U,$J,358.4,237,0)
- +478 ;;=FINE NEEDLE ASPIRATION BIOPSY^14^25
- +479 ;;^UTILITY(U,$J,358.4,238,0)
- +480 ;;=A DIAGNOSES^2^26
- +481 ;;^UTILITY(U,$J,358.4,239,0)
- +482 ;;=D DIAGNOSES^5^26
- +483 ;;^UTILITY(U,$J,358.4,240,0)
- +484 ;;=E DIAGNOSES^6^26
- +485 ;;^UTILITY(U,$J,358.4,241,0)
- +486 ;;=F DIAGNOSES^7^26
- +487 ;;^UTILITY(U,$J,358.4,242,0)
- +488 ;;=I DIAGNOSES^10^26
- +489 ;;^UTILITY(U,$J,358.4,243,0)
- +490 ;;=K DIAGNOSES^11^26
- +491 ;;^UTILITY(U,$J,358.4,244,0)
- +492 ;;=M DIAGNOSES^13^26
- +493 ;;^UTILITY(U,$J,358.4,245,0)
- +494 ;;=N DIAGNOSES^14^26
- +495 ;;^UTILITY(U,$J,358.4,246,0)
- +496 ;;=P DIAGNOSES^16^26
- +497 ;;^UTILITY(U,$J,358.4,247,0)
- +498 ;;=R DIAGNOSES^17^26
- +499 ;;^UTILITY(U,$J,358.4,248,0)
- +500 ;;=S DIAGNOSES^18^26
- +501 ;;^UTILITY(U,$J,358.4,249,0)
- +502 ;;=T DIAGNOSES^20^26
- +503 ;;^UTILITY(U,$J,358.4,250,0)
- +504 ;;=V DIAGNOSES^22^26
- +505 ;;^UTILITY(U,$J,358.4,251,0)
- +506 ;;=X DIAGNOSES^24^26
- +507 ;;^UTILITY(U,$J,358.4,252,0)
- +508 ;;=C DIAGNOSES^4^26
- +509 ;;^UTILITY(U,$J,358.4,253,0)
- +510 ;;=W DIAGNOSES^23^26
- +511 ;;^UTILITY(U,$J,358.4,254,0)
- +512 ;;=B DIAGNOSES^3^26
- +513 ;;^UTILITY(U,$J,358.4,255,0)
- +514 ;;=G DIAGNOSES^8^26
- +515 ;;^UTILITY(U,$J,358.4,256,0)
- +516 ;;=H DIAGNOSES^8^26
- +517 ;;^UTILITY(U,$J,358.4,257,0)
- +518 ;;=L DIAGNOSES^12^26
- +519 ;;^UTILITY(U,$J,358.4,258,0)
- +520 ;;=O DIAGNOSES^15^26
- +521 ;;^UTILITY(U,$J,358.4,259,0)
- +522 ;;=U DIAGNOSES^21^26
- +523 ;;^UTILITY(U,$J,358.4,260,0)
- +524 ;;=Z DIAGNOSES^25^26
- +525 ;;^UTILITY(U,$J,358.4,261,0)
- +526 ;;=SUICIDE IDEATIONS/ATTEMPTS^19^26
- +527 ;;^UTILITY(U,$J,358.4,262,0)
- +528 ;;=MOST COMMON DX^1^26
- +529 ;;^UTILITY(U,$J,358.4,263,0)
- +530 ;;=NEW PATIENT^3^27
- +531 ;;^UTILITY(U,$J,358.4,264,0)
- +532 ;;=ESTABLISHED PATIENT^1^27
- +533 ;;^UTILITY(U,$J,358.4,265,0)
- +534 ;;=CONSULTATIONS^2^27
- +535 ;;^UTILITY(U,$J,358.4,266,0)
- +536 ;;=PREVENTIVE MEDICINE-EST PT^4^27
- +537 ;;^UTILITY(U,$J,358.4,267,0)
- +538 ;;=PREVENTIVE MEDICINE-NEW PT^5^27
- +539 ;;^UTILITY(U,$J,358.4,268,0)
- +540 ;;=RISK FACTOR REDUCTION-GRP^6^27
- +541 ;;^UTILITY(U,$J,358.4,269,0)
- +542 ;;=RISK FACTOR REDUCTION-IND^7^27
- +543 ;;^UTILITY(U,$J,358.4,270,0)
- +544 ;;=OTHER^3^28
- +545 ;;^UTILITY(U,$J,358.4,271,0)
- +546 ;;=EDUCATION/TRAINING^1^28
- +547 ;;^UTILITY(U,$J,358.4,272,0)
- +548 ;;=MEDICAL NUTRITION THERAPY^2^28
- +549 ;;^UTILITY(U,$J,358.4,273,0)
- +550 ;;=WOUND TREATMENT^5^28
- +551 ;;^UTILITY(U,$J,358.4,274,0)
- +552 ;;=PROLONGED SERVICES^4^28
- +553 ;;^UTILITY(U,$J,358.4,275,0)
- +554 ;;=DIABETES^1^29
- +555 ;;^UTILITY(U,$J,358.4,276,0)
- +556 ;;=SUICIDE IDEATIONS/ATTEMPTS^2^29
- +557 ;;^UTILITY(U,$J,358.4,277,0)
- +558 ;;=NEW PATIENT^2^30
- +559 ;;^UTILITY(U,$J,358.4,278,0)
- +560 ;;=ESTABLISHED PATIENT^1^30
- +561 ;;^UTILITY(U,$J,358.4,279,0)
- +562 ;;=CONSULTATIONS^3^30
- +563 ;;^UTILITY(U,$J,358.4,280,0)
- +564 ;;=ENDOCRINE DX^1^31
- +565 ;;^UTILITY(U,$J,358.4,281,0)
- +566 ;;=SUICIDE IDEATIONS/ATTEMPTS^2^31
- +567 ;;^UTILITY(U,$J,358.4,282,0)
- +568 ;;=BIOPSIES^1^32
- +569 ;;^UTILITY(U,$J,358.4,283,0)
- +570 ;;=INJECTIONS & INFUSIONS^2^32
- +571 ;;^UTILITY(U,$J,358.4,284,0)
- +572 ;;=OTHER^4^32
- +573 ;;^UTILITY(U,$J,358.4,285,0)
- +574 ;;=PROLONGED CLINICAL STAFF SERVICES^5^32
- +575 ;;^UTILITY(U,$J,358.4,286,0)
- +576 ;;=LAB TESTS^3^32
- +577 ;;^UTILITY(U,$J,358.4,287,0)
- +578 ;;=NEW PATIENT^3^33
- +579 ;;^UTILITY(U,$J,358.4,288,0)
- +580 ;;=ESTABLISHED PATIENT^2^33
- +581 ;;^UTILITY(U,$J,358.4,289,0)
- +582 ;;=CONSULTS - OUTPT^4^33
- +583 ;;^UTILITY(U,$J,358.4,290,0)
- +584 ;;=EYE CODES^1^33
- +585 ;;^UTILITY(U,$J,358.4,291,0)
- +586 ;;=CONSULTS - INPT^5^33
- +587 ;;^UTILITY(U,$J,358.4,292,0)
- +588 ;;=HOSPITAL CARE - INITIAL^6^33
- +589 ;;^UTILITY(U,$J,358.4,293,0)
- +590 ;;=HOSPITAL CARE - SUBSEQUENT^7^33
- +591 ;;^UTILITY(U,$J,358.4,294,0)
- +592 ;;=HOSPITAL CARE - DISCHARGE^8^33
- +593 ;;^UTILITY(U,$J,358.4,295,0)
- +594 ;;=OBSERVATION CARE - INITIAL^9^33
- +595 ;;^UTILITY(U,$J,358.4,296,0)
- +596 ;;=OBSERVATION CARE - SUBSEQUENT^10^33
- +597 ;;^UTILITY(U,$J,358.4,297,0)
- +598 ;;=OBSERVATION CARE - DISCHARGE^11^33
- +599 ;;^UTILITY(U,$J,358.4,298,0)
- +600 ;;=INPT or OBS - ADMIT & DISCHARGE SAME DAY^12^33
- +601 ;;^UTILITY(U,$J,358.4,299,0)
- +602 ;;=EEF Version 2022 April^13^33
- +603 ;;^UTILITY(U,$J,358.4,300,0)
- +604 ;;=PROC - LID / LACRIMAL^7^34
- +605 ;;^UTILITY(U,$J,358.4,301,0)
- +606 ;;=PROC - LASER / CRYO^10^34
- +607 ;;^UTILITY(U,$J,358.4,302,0)
- +608 ;;=PROC - CORNEA / CONJ^6^34
- +609 ;;^UTILITY(U,$J,358.4,303,0)
- +610 ;;=MEDICATIONS^12^34
- +611 ;;^UTILITY(U,$J,358.4,304,0)
- +612 ;;=PROC - INJECTIONS / ALL^9^34
- +613 ;;^UTILITY(U,$J,358.4,305,0)
- +614 ;;=IMAGE / PHOTOS^2^34
- +615 ;;^UTILITY(U,$J,358.4,306,0)
- +616 ;;=REFRACT / GLASSES / CL^1^34
- +617 ;;^UTILITY(U,$J,358.4,307,0)
- +618 ;;=TEST - CATARACT / CORNEA^4^34
- +619 ;;^UTILITY(U,$J,358.4,308,0)
- +620 ;;=TEST - GLAUCOMA^3^34
- +621 ;;^UTILITY(U,$J,358.4,309,0)
- +622 ;;=TEST - OTHER^5^34
- +623 ;;^UTILITY(U,$J,358.4,310,0)
- +624 ;;=EDUCATION / COUNSELING^13^34
- +625 ;;^UTILITY(U,$J,358.4,311,0)
- +626 ;;=EYE SURGERY CODES^11^34
- +627 ;;^UTILITY(U,$J,358.4,312,0)
- +628 ;;=PROC - INJECTIONS / VEGF^8^34
- +629 ;;^UTILITY(U,$J,358.4,313,0)
- +630 ;;=TEST - ERG / VEP^14^34
- +631 ;;^UTILITY(U,$J,358.4,314,0)
- +632 ;;=LOW VISION / BLINDNESS^21^35
- +633 ;;^UTILITY(U,$J,358.4,315,0)
- +634 ;;=RETINA - VASCULAR^12^35
- +635 ;;^UTILITY(U,$J,358.4,316,0)
- +636 ;;=EYELIDS / LASHES^2^35
- +637 ;;^UTILITY(U,$J,358.4,317,0)
- +638 ;;=NEURO / STRABISMUS^18^35
- +639 ;;^UTILITY(U,$J,358.4,318,0)
- +640 ;;=ORBIT - PLASTICS^20^35
- +641 ;;^UTILITY(U,$J,358.4,319,0)
- +642 ;;=VITREOUS^17^35
- +643 ;;^UTILITY(U,$J,358.4,320,0)
- +644 ;;=ORBIT - TRAUMA^19^35
- +645 ;;^UTILITY(U,$J,358.4,321,0)
- +646 ;;=LACRIMAL / NLD / NEOPLASMS^3^35
- +647 ;;^UTILITY(U,$J,358.4,322,0)
- +648 ;;=MOST FREQUENT^1^35